Frank McCormick

Active 1980–2025

288
Papers
84,666
Citations
145
h-index
281
i10-index

Citations

Citations per year for Frank McCormick1951: 1 citations1955: 1 citations1979: 1 citations1981: 10 citations1982: 7 citations1983: 6 citations1984: 11 citations1985: 9 citations1986: 43 citations1987: 40 citations1988: 66 citations1989: 140 citations1990: 324 citations1991: 590 citations1992: 638 citations1993: 658 citations1994: 783 citations1995: 673 citations1996: 743 citations1997: 798 citations1998: 781 citations1999: 806 citations2000: 881 citations2001: 902 citations2002: 761 citations2003: 708 citations2004: 639 citations2005: 698 citations2006: 606 citations2007: 630 citations2008: 560 citations2009: 609 citations2010: 579 citations2011: 587 citations2012: 521 citations2013: 493 citations2014: 560 citations2015: 522 citations2016: 518 citations2017: 512 citations2018: 512 citations2019: 1,780 citations2020: 1,967 citations2021: 2,112 citations2022: 1,690 citations2023: 1,294 citations2024: 1,835 citations2025: 881 citations2026: 35 citations1952–1954: no citations, so these years are not shown1956–1978: no citations, so these years are not shown1980: no citations, so this year is not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 12,346 citing papers, 37.9% of this breakdownChina: 3,285 citing papers, 10.1% of this breakdownUnited Kingdom: 2,024 citing papers, 6.2% of this breakdownGermany: 1,758 citing papers, 5.4% of this breakdownJapan: 1,407 citing papers, 4.3% of this breakdownCanada: 1,188 citing papers, 3.7% of this breakdownFrance: 1,048 citing papers, 3.2% of this breakdownItaly: 929 citing papers, 2.9% of this breakdownSpain: 677 citing papers, 2.1% of this breakdownNetherlands: 629 citing papers, 1.9% of this breakdownAustralia: 622 citing papers, 1.9% of this breakdownSwitzerland: 515 citing papers, 1.6% of this breakdown
0%37.9%Other 18.8%

Fields

  • Biochemistry, Genetics and Molecular Biology57.7%
  • Medicine34%
  • Immunology and Microbiology2.5%
  • Neuroscience1.8%
  • Computer Science0.8%
  • Agricultural and Biological Sciences0.5%
  • Other2.7%

Topics

  • Protein Kinase Regulation and GTPase Signaling4.7%
  • PI3K/AKT/mTOR signaling in cancer2.5%
  • Cancer-related Molecular Pathways2.4%
  • Wnt/β-catenin signaling in development and cancer2.3%
  • Melanoma and MAPK Pathways1.9%
  • Epigenetics and DNA Methylation1.8%
  • Other84.4%

Coauthors

All papers

Open in search
  1. Oncogenic Signaling Pathways in The Cancer Genome Atlas

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Peter W. Laird, Gregory P. Way, Casey S. Greene, Han Liang, Yonghong Xiao, Chen Wang, Antonio Iavarone, Alice H. Berger, Trever G. Bivona, Alexander J. Lazar, Gary D. Hammer, Thomas J. Giordano, Lawrence N. Kwong, Grant A. McArthur, Chenfei Huang, Aaron D. Tward, Mitchell J. Frederick, Frank McCormick, Matthew Meyerson, Rory Johnson, John A. Demchok, Ina Felau, Melpomeni Kasapi, Martin L. Ferguson, Carolyn M. Hutter, Heidi J. Sofia, Roy Tarnuzzer, Zhining Wang, Liming Yang, Jean C. Zenklusen, Jiashan Zhang, Sudha Chudamani, Jia Liu, Laxmi Lolla, Rashi Naresh, Todd Pihl, Qiang Sun, Yunhu Wan, Ye Wu, Juok Cho, Timothy Defreitas, Scott Frazer, Nils Gehlenborg, Gad Getz, David I. Heiman, Jaegil Kim, Michael S. Lawrence, Pei Lin, Sam Meier, Michael S. Noble, Gordon Saksena, Doug Voet, Hailei Zhang, Brady Bernard, Nyasha Chambwe, Varsha Dhankani, Theo Knijnenburg, Roger Kramer, Kalle Leinonen, Yuexin Liu, Michael Miller, Sheila M. Reynolds, Ilya Shmulevich, Vésteinn Thórsson, Wei Zhang, Rehan Akbani, Bradley M. Broom, Apurva M. Hegde, Zhenlin Ju, Rupa S. Kanchi and 679 more - Cell 2018 cited by 3,424

  2. Drug-tolerant persister cancer cells are vulnerable to GPX4 inhibition

    Authors: , , , , , , , , , , , - Nature 2017 cited by 1,804

  3. RAS Proteins and Their Regulators in Human Disease

    Authors: , , - Cell 2017 cited by 1,975

  4. RAS-targeted therapies: is the undruggable drugged?

    Authors: , , , - Nature Reviews Drug Discovery 2020 cited by 1,070

  5. The metabolic landscape of RAS-driven cancers from biology to therapy

    Authors: , , - Nature Cancer 2021 cited by 354

  6. A collection of breast cancer cell lines for the study of functionally distinct cancer subtypes

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , - Cancer Cell 2006 cited by 3,231

  7. Glutamine Sensitivity Analysis Identifies the xCT Antiporter as a Common Triple-Negative Breast Tumor Therapeutic Target

    Authors: , , , , , , , , , , , , - Cancer Cell 2013 cited by 570

  8. Aurora kinase A drives the evolution of resistance to third-generation EGFR inhibitors in lung cancer

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , - Nature Medicine 2018 cited by 286

  9. Targeting RAF kinases for cancer therapy: BRAF-mutated melanoma and beyond

    Authors: , , , - Nature reviews. Cancer 2014 cited by 827

  10. Undermining Glutaminolysis Bolsters Chemotherapy While NRF2 Promotes Chemoresistance in KRAS-Driven Pancreatic Cancers

    Authors: , , , , , , , , - Cancer Research 2020 cited by 315

  11. The RB and p53 pathways in cancer

    Authors: , - Cancer Cell 2002 cited by 1,667

  12. Dragging Ras Back in the Ring

    Authors: , , , - Cancer Cell 2014 cited by 803

  13. Notch promotes epithelial-mesenchymal transition during cardiac development and oncogenic transformation

    Authors: , , , , , , , , , , - Genes & Development 2003 cited by 982

  14. Structure–function analysis of the SHOC2–MRAS–PP1C holophosphatase complex

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , - Nature 2022 cited by 85

  15. The GTPase superfamily: conserved structure and molecular mechanism

    Authors: , , - Nature 1991 cited by 3,409

  16. β-Catenin regulates expression of cyclin D1 in colon carcinoma cells

    Authors: , - Nature 1999 cited by 3,607

  17. An Adenovirus Mutant That Replicates Selectively in p53- Deficient Human Tumor Cells

    Authors: , , , , , , , , , , - Science 1996 cited by 1,762

  18. ssGSEA score-based Ras dependency indexes derived from gene expression data reveal potential Ras addiction mechanisms with possible clinical implications

    Authors: , , , - Scientific Reports 2020 cited by 255

  19. Machine learning–driven multiscale modeling reveals lipid-dependent dynamics of RAS signaling proteins

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Arthur F. Voter, Arvind Ramanathan, Nicolas Hengartner, Dhirendra K. Simanshu, Andrew G. Stephen, Peer‐Timo Bremer, S. Gnanakaran, James N. Glosli, Felice C. Lightstone, Frank McCormick, Dwight V. Nissley, Frederick H. Streitz - National Academy of Sciences, Proceedings of the National Academy of Sciences 2022 cited by 87

  20. More to the RAS Story: KRASG12C Inhibition, Resistance Mechanisms, and Moving Beyond KRASG12C

    Authors: , , , - American Society of Clinical Oncology Educational Book 2022 cited by 37

  21. Enhancing Tumor-Specific Uptake of the Anticancer Drug Cisplatin with a Copper Chelator

    Authors: , , , - Cancer Cell 2010 cited by 287

  22. Adenovirus E4ORF1-Induced MYC Activation Promotes Host Cell Anabolic Glucose Metabolism and Virus Replication

    Authors: , , , , , , , , - Cell Metabolism 2014 cited by 281

  23. KRAS G13D sensitivity to neurofibromin-mediated GTP hydrolysis

    Authors: , , , , , , - National Academy of Sciences, Proceedings of the National Academy of Sciences 2019 cited by 129

  24. Structure of the SHOC2–MRAS–PP1C complex provides insights into RAF activation and Noonan syndrome

    Authors: , , , , , , , , , , , , - Nature Structural & Molecular Biology 2022 cited by 52